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The implantation of transvenous leads for pacemakers and
deﬁbrillators is traditionally performed using ﬂuoroscopic
guidance. When cardiac resynchronization therapy (CRT) is
indicated, iodine contrast medium (ICM) infusion for
coronary sinus (CS) branch visualization is also needed.
Adverse reactions to ICM during cardiac catheterization
and coronary interventions are common.1 Chronic kidney
disease (CKD) is frequently present in a population with
symptomatic heart failure.2 Contrast-induced acute kidney
injury is a serious and frequent procedural complication of
CRT implantation with a signiﬁcant negative inﬂuence on
long-term survival.3
The feasibility of cardiac resynchronization therapy-
deﬁbrillator (CRT-D) implantation guided by an advanced
electroanatomic mapping system (MS), without contrast
liquid infusion, is already reported in the literature.4 More-
over, using the MS to ﬁnd the latest left ventricle activation
site, it is possible to optimize the left ventricle (LV) lead
position.5Case report
An 87-year-old woman with nonischemic cardiomyopathy,
left branch bundle block, left ventricular ejection fraction
42%, CKD (glomerular ﬁltration rate ¼ 25 mL/min/1.73
m2), and chronic atrial ﬁbrillation was selected for cardiac
resynchronization therapy-pacemaker (CRT-P) implantation.
She experienced 2 hospitalizations owing to heart failure
worsening in the previous 6 months, and also owing to fastKEYWORDS ardiac resynchronization therapy; Electroanatomic mapping;
Contrast medium; Chronic kidney disease; AV node ablation
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reported in her clinical history.
The implantation was performed using the EnSite Velocity
NavX system, version 4.0.1 (St Jude Medical, St Paul, MN).
The EnSite electroanatomicMS can be used to create geometric
models of the cardiac chambers and allows conﬁrmation of the
catheters’ location in the 3-dimensional space in real time,
minimizing the use of ﬂuoroscopy. The MS allows visualizing
and mapping by continuous acquisition of signals from all
catheters, leads, and unipolar guidewires.
A decapolar diagnostic electrophysiological catheter with
a very soft tip (Livewire 5F; St Jude Medical), connected to
the EnSite box (CathLink) of the MS, was introduced via the
delivery system through the left subclavian vein and was
used to create the right ventricular (RV) septal anatomy and
to cannulate the CS without ﬂuoroscopy.
The bipolar RV lead (Isoﬂex 1948; St Jude Medical) was
delivered via the left cephalic vein; it was connected to the
MS by means of pacing threshold cables with crocodile clips
(401748; St Jude Medical) and positioned in the RV apex,
under continuous MS monitoring.
The delivery system (Cardiac Positioning System, CPS; St
Jude Medical) was pushed over the decapolar lead into the CS.
The decapolar lead was then removed and the VisionWire
(0.014” insulated unipolar guidewire; Biotronik, Berlin, Ger-
many) was connected to the MS by means of the above-
mentioned threshold cables and introduced into the CS to ﬁnd
all the available collateral branches and to create the electro-
anatomic mapping. This guidewire has an insulated body and
conductive distal tip and this feature makes it appear like a
unipolar catheter in the EnSite mapping system. The guidewire
allowed us to deeply explore the branches, to acquire the local
intracardiac signal, and to deliver, over the wire, the permanent
LV lead to the target site. The CS branches were detected
without use of contrast liquid infusion and ﬂuoroscopy.
Three LV veins were cannulated with the guidewire and
analyzed: a posterior vein (middle), a posterolateral vein, and
an anterior vein. During the entire CS exploration, the local
activation time map was acquired in order to investigate thepen access article under the CC BY-NC-ND license
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KEY TEACHING POINTS
 Cardiac resynchronization therapy (CRT)
implantation procedure, in the common practice,
requires contrast medium infusion to visualize
coronary sinus collateral branches, but it is harmful
in patients with chronic kidney disease or allergy.
 CRT implantation guided by electroanatomic
mapping may be helpful to avoid the contrast
medium infusion.
 The electroanatomic mapping allows optimization
of left ventricle pacing lead positioning by
identifying the most electrically delayed site, with
a reduced ﬂuoroscopy exposure time.
245Calzolari et al CRT Device Implantation Guided by Mapping Systemlocal electrical delay from the onset of QRS. The optimal
position of the CS lead (Quartet 1458Q; St Jude Medical)
was chosen following the criterion of the most delayed site,
during spontaneous activation of the LV (Figure 1).
The most delayed activation was recorded in a small vein,
a tributary of the posterolateral branch. It was not possible to
position the lead in this site owing to its small size.
The adjacent site, in the mid portion of the posterolateral
vein, was selected as the target site, with electrical delay ofFigure 1 Final activation map of coronary sinus tributary veins during spontaneo
2 views (corresponding to left and right anterior oblique views) (top). In the color r
onset of QRS. Electrical signals from RV apical lead, surface lead, and distal and105 ms from the onset of QRS (Figure 1). Here, the electrical
parameters (pacing threshold, sensing, and impedance) and
the lead stability were optimal.
The LV and RV leads were connected to the CRT-P device
(Quadra Allure MP PM3262; St Jude Medical). The atrial port
was plugged owing to chronic atrial ﬁbrillation. The distal
dipole of the quadripolar lead was chosen for the LV pacing
because it corresponded to the latest activated site.
At the end of the implantation procedure, an ablation
catheter (Saﬁre 4 mm; St Jude Medical) was inserted through
the femoral vein and guided to the atrioventricular (AV)
node by means of the previously created anatomic map.
Sixty seconds of radiofrequency energy at 50 watts was
delivered for effective AV node ablation (Figure 2). No
additional ﬂuoroscopy was used for this ﬁnal step.
The procedure was completed in 120 minutes, with less
than 4 minutes of ﬂuoroscopy. No ICM was used.
The comparison of electrocardiogram signals pre- and
post-procedure (Figure 3) showed QRS narrowing from 160
ms to 145 ms.Discussion
In our experience of CRT implantations we usually use
ﬂuoroscopy guide and contrast medium infusion to ﬁnd and
visualize the CS and its branches. Taking advantage of ourus rhythm and ﬁnal position of right (RV) and left ventricular (LV) leads in
ange, blue and purple represent the latest activated sites with respect to the
proximal dipoles of quadripolar LV lead, respectively (bottom).
Figure 2 Atrioventricular (AV) node ablation. Yellow dot is the tag of His bundle. AV block during radiofrequency ablation.
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electrophysiology procedures, for the ﬁrst time in our center we
usedMS in CRT device implantation for LV lead positioning in
order to avoid the infusion of contrast medium in a CKD and
ICM-allergic patient. The method described by Del Greco et al4
for CRT-D implantation guided by electroanatomic MS is
reproducible and feasible. The device implantation was com-
pleted without complications, with a procedural time compa-
rable to a traditional approach and with a reduced ﬂuoroscopy
time.6 The use of contrast medium was avoided, thus minimiz-
ing the risk of complications related to worsening of kidney
disease and the patient’s allergy. We believe that, besides the
non-use of ICM and the ﬂuoroscopy reduction, the beneﬁts
derived by this technique are to be able to leave a clear trace of
each vessel and to go back quickly and easily into it. Moreover,
theMS allows one to draw not only an anatomic map (collateralFigure 3 Pre (left side) and post (right side) pCS branches) but also a picture of electrical activation in order
to choose the right vessel and the right site within it (latest
activated site7). The MS was extremely useful in guiding the
LV catheter placement. The lead was positioned in the most
delayed of all the available vessels to obtain the greatest
increase in cardiac contractility.8 This approach allowed
achieving a complete map of the CS vessels’ electrical
activation, without the need for single-point recording.8,9 In
our experience, the use of the previously acquired anatomic
map allowed a safe and effective AV node ablation.
Using this approach in patients without contraindications
to use of ICM, we cannot exclude the presence of further
lateral vessels that are not selected with the wire. The
guidewire allows drawing of the vessel but does not give
information about its size in relation to the LV lead caliber.
Another possible limitation is that this technique is feasibleacemaker implantation electrocardiogram.
247Calzolari et al CRT Device Implantation Guided by Mapping Systemonly with the EnSite, the unique mapping system that allows
visualizing every catheter, lead, and unipolar guidewire.
Conclusion
This case conﬁrmed that CRT implantation by means of
electroanatomic mapping, in a patient with contraindications
to ICM, was feasible, safe, and effective, and it did not
require any speciﬁc learning curve. The approach also
yielded a further beneﬁt regarding choosing the most
appropriate LV target site for better CRT response.
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